Alphatec Holdingsの空売り状況は、投資家がAlphatec Holdingsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Alphatec Holdings (NASDAQ:ATEC) 株価情報, 空売り情報

Alphatec Holdings

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Alphatec Holdings Inc

Atec Inc

Barclays analyst Matt Miksic maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Overweight and raises the price target from $19 to $20.

News

Price Target

Analyst Ratings

ATEC

Barclays Maintains Overweight on Alphatec Holdings, Raises Price Target to $20

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping around 500 points on Thursday.
The Dow traded down 0.62% to 41,880.03 while the NASDAQ fell 2.69% to 18,107.65. The S&amp;P 500 also fell, dropping, 1.64% to 5,718.50.
Check This Out: <a href="https://www.benzinga.com/news/24/10/41653495/top-2-real-estate-stocks-you-may-want-to-dump-this-quarter">Top 2 Real Estate Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Utilities shares rose by 1.6% on Thursday.
In trading on Thursday, information technology shares fell by 3.4%.
Top Headline
Shares of Uber Technologies, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) dipped more than 10% on Thursday after the company reported quarterly results.
The company posted fiscal third-quarter 2024 revenue growth of 20% year-on-year to $11.188 billion, beating the analyst consensus of $10.97 billion. Uber reported GAAP EPS of 46 cents and adjusted EPS of 46 cents, which beat the analyst consensus of 41 cents.
Trips grew 17% year-over-year to 2.9 billion, or 31 million per day. Uber&#8217;s Monthly Active Platform Consumers reached 161 million, up 13% year-over-year.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Root, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) shares shot up 77% to $72.03 after the company reported better-than-expected third-quarter financial results.</li>
<li>Shares of Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) got a boost, surging 39% to $7.82 after the company reported better-than-expected third-quarter revenue results and raised its FY24 revenue guidance.</li>
<li>Lemonade, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) shares were also up, gaining 27% to $23.89 after the company reported third-quarter earnings and sales above estimates and raised its FY24 guidance.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Matinas BioPharma Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTNB#NYSE">MTNB</a>) shares dropped 65% to $0.6700 after the company announced the termination of negotiations under the previously disclosed non-binding term sheet regarding global rights to MAT2203. Matinas has implemented an 80% reduction in its workforce.</li>
<li>Shares of Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) were down 24% to $5.01 after reporting a wider-than-expected quarterly loss.</li>
<li>COMPASS Pathways plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) was down, falling 23% to $4.7750 after the company announced it pushed its topline data readout from its COMP005 Phase 3 trial to Q2 2025 and its COMP006 data will be announced after the 26-week time point.</li>
</ul>
Commodities In commodity news, oil traded up 1% to $69.30 while gold traded down 1.8% at $2,751.50.
Silver traded down 3.7% to $32.820 on Thursday, while copper fell 0.1% to $4.3475.
Euro zone
European shares were lower today. The eurozone's STOXX 600 dipped 1.20%, Germany's DAX fell 0.93% and France's CAC 40 slipped 1.05%. Spain's IBEX 35 Index fell 0.36%, while London's FTSE 100 fell 0.61%.
Asia Pacific Markets
Asian markets closed mostly lower on Thursday, with Japan's Nikkei 225 falling 0.50%, Hong Kong's Hang Seng Index falling 0.31%, China's Shanghai Composite Index gaining 0.42% and India's BSE Sensex falling 0.69%.
Economics
<ul>
<li>U.S. initial jobless claims declined by 12,000 from the previous week to 216,000 in the week ending Oct. 26.</li>
<li>U.S. personal income increased by 0.3% from the prior month to $24.948 trillion in September, while personal spending increased by 0.5% to an annualized rate of $20.024 trillion.</li>
<li>The personal consumption expenditure price index rose 0.2% month-over-month in September following a 0.1% increase in August.</li>
<li>U.S. natural-gas supplies rose 78 billion cubic feet to 8.863 trillion cubic feet in the week ended Oct. 25.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41652163/jim-cramer-this-financial-stock-is-one-of-the-most-consistent-great-companies">Jim Cramer: This Financial Stock Is &#8216;One Of The Most Consistent, Great Companies&#8217;</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

CMPS

LMND

MTNB

ROOT

UBER

Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results

U.S. stocks traded lower midway through trading, with the Dow Jones index more than 300 points on Thursday.
The Dow traded down 0.78% to 41,810.80 while the NASDAQ fell 2.46% to 18,149.38. The S&amp;P 500 also fell, dropping, 1.56% to 5,723.19.
Check This Out: <a href="https://www.benzinga.com/news/24/10/41653495/top-2-real-estate-stocks-you-may-want-to-dump-this-quarter">Top 2 Real Estate Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Energy shares rose by 1.1% on Thursday.
In trading on Thursday, information technology shares fell by 3%.
Top Headline
Shares of Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) fell more than 2% on Thursday after the company reported third-quarter financial results.
The company reported third-quarter revenue of $40.59 billion, beating analyst estimates of $40.29 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Root, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) shares shot up 180% to $113.43 after the company reported better-than-expected third-quarter financial results.</li>
<li>Shares of Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) got a boost, surging 39% to $7.79 after the company reported better-than-expected third-quarter revenue results and raised its FY24 revenue guidance.</li>
<li>Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) shares were also up, gaining 39% to $7.78 after the company reported better-than-expected third-quarter revenue results and raised its FY24 revenue guidance.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Matinas BioPharma Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTNB#NYSE">MTNB</a>) shares dropped 69% to $0.6100 after the company announced the termination of negotiations under the previously disclosed non-binding term sheet regarding global rights to MAT2203. Matinas has implemented an 80% reduction in its workforce.</li>
<li>Shares of Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) were down 24% to $5.0200 after reporting a wider-than-expected quarterly loss.</li>
<li>COMPASS Pathways plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) was down, falling 25% to $4.6650 after the company announced it pushed its topline data readout from its COMP005 Phase 3 trial to Q2 2025 and its COMP006 data will be announced after the 26-week time point.</li>
</ul>
Commodities In commodity news, oil traded up 1.2% to $69.40 while gold traded down 1.4% at $2,763.10.
Silver traded down 3.2% to $32.970 on Thursday, while copper rose 0.2% to $4.3585.
Euro zone
European shares were lower today. The eurozone's STOXX 600 dipped 1.29%, Germany's DAX fell 0.95% and France's CAC 40 slipped 1.15%. Spain's IBEX 35 Index fell 0.53%, while London's FTSE 100 fell 0.91%.
Asia Pacific Markets
Asian markets closed mostly lower on Thursday, with Japan's Nikkei 225 falling 0.50%, Hong Kong's Hang Seng Index falling 0.31%, China's Shanghai Composite Index gaining 0.42% and India's BSE Sensex falling 0.69%.
Economics
<ul>
<li>U.S. initial jobless claims declined by 12,000 from the previous week to 216,000 in the week ending Oct. 26.</li>
<li>U.S. personal income increased by 0.3% from the prior month to $24.948 trillion in September, while personal spending increased by 0.5% to an annualized rate of $20.024 trillion.</li>
<li>The personal consumption expenditure price index rose 0.2% month-over-month in September following a 0.1% increase in August.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41652163/jim-cramer-this-financial-stock-is-one-of-the-most-consistent-great-companies">Jim Cramer: This Financial Stock Is &#8216;One Of The Most Consistent, Great Companies&#8217;</a></li>
</ul>

Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results

U.S. stocks were lower, with the Dow Jones index falling around 200 points on Thursday.
Shares of Roblox Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) rose sharply during Thursday&#8217;s session after the company reported better-than-expected third-quarter financial results and reported a year-over-year increase in daily <a href="https://www.benzinga.com/news/earnings/24/10/41654520/roblox-q3-earnings-bookings-jump-34-user-base-hits-89-million-raises-annual-outlook">active users and hours engaged</a>.
The video game developer reported an adjusted EPS loss of 37 cents, beating the analyst consensus loss estimate of 0.39 cents. The revenue of the American video game developer grew by 29% Y/Y to $919 million.
Roblox shares climbed 21.5% to $52.13 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Root, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) shares jumped 138% to $96.39 after the company reported better-than-expected third-quarter financial results.</li>
<li>Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) shares climbed 40% to $7.84 after the company reported better-than-expected third-quarter revenue results and raised its FY24 revenue guidance.</li>
<li>Lemonade, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) surged 25.8% to $23.59 after the company reported third-quarter earnings and sales above estimates and raised its FY24 guidance.</li>
<li>Paycom Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) gained 24.7% to $214.84 following better-than-expected quarterly earnings.</li>
<li>Confluent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) rose 21.4% to $28.00 after the company reported better-than-expected quarterly financial results.</li>
<li>Remitly Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELY#NASDAQ">RELY</a>) surged 19.7% to $18.27 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates.</li>
<li>Nextracker Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) gained 19.1% to $38.09 after the company reported better-than-expected second-quarter financial results and raised its FY25 GAAP and adjusted EPS guidance.</li>
<li>Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) rose 18.6% to $7.89 after the company reported better-than-expected quarterly sales.</li>
<li>TTM Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) surged 16.6% to $23.01 following strong quarterly sales.</li>
<li>Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) gained 16% to $81.81 after the company reported better-than-expected third-quarter financial results.</li>
<li>International Paper Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>) rose 14% to $55.91 after the company reported better-than-expected quarterly adjusted EPS results. The company announced the decision to review strategic options for its global cellulose fibers business.</li>
<li>Entergy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) gained 11.8% to $150.32 after the company reported better-than-expected third-quarter earnings and raised FY24 EPS outlook.</li>
<li>Gen Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) gained 10.1% to $29.64 following strong quarterly sales.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) rose 10.1% to $130.98 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance above estimates.</li>
<li>Norwegian Cruise Line Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) gained 7.7% to $25.69 after the company reported better-than-expected quarterly financial results.</li>
<li>Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) gained 7% to $54.03 following strong earnings.</li>
<li>Booking Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) rose 6.3% to $4,745.96 after the company reported better-than-expected third-quarter financial results.</li>
</ul>
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41652163/jim-cramer-this-financial-stock-is-one-of-the-most-consistent-great-companies"> Jim Cramer: This Financial Stock Is &#8216;One Of The Most Consistent, Great Companies&#8217;</a></li>
</ul>

Movers

BKNG

CFLT

NCLH

PAYC

PTON

RBLX

RELY

TTMI

TWLO

Roblox Posts Upbeat Results, Joins Paycom Software, Norwegian Cruise Line, Altria Group, Booking And Other Big Stocks Moving Higher On Thursday

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Thursday.
The Dow traded down 0.40% to 41,972.69 while the NASDAQ fell 1.24% to 18,377.20. The S&amp;P 500 also fell, dropping, 0.76% to 5,769.76.
Check This Out: <a href="https://www.benzinga.com/news/24/10/41653495/top-2-real-estate-stocks-you-may-want-to-dump-this-quarter">Top 2 Real Estate Stocks You May Want To Dump This Quarter</a>
Leading and Lagging Sectors Energy shares rose by 1% on Thursday.
In trading on Thursday, information technology shares fell by 2.1%.
Top Headline
Shares of Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) fell around 5% on Thursday after the company reported first-quarter financial results.
The company reported first-quarter revenue of $65.60 billion, up 16% year-over-year. The total beat a Street consensus estimate of $64.51 billion according to data from Benzinga Pro.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Root, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) shares shot up 138% to $96.39 after the company reported better-than-expected third-quarter financial results.</li>
<li>Shares of 1847 Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#NYSE">EFSH</a>) got a boost, surging 66% to $0.6451. 1847 Holdings announced the closing of $11.1 million public offering</li>
<li>Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) shares were also up, gaining 40% to $7.84 after the company reported better-than-expected third-quarter revenue results and raised its FY24 revenue guidance.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Matinas BioPharma Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTNB#NYSE">MTNB</a>) shares dropped 64% to $0.7000 after the company announced the termination of negotiations under the previously disclosed non-binding term sheet regarding global rights to MAT2203. Matinas has implemented an 80% reduction in its workforce.</li>
<li>Shares of MDJM Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDJH#NASDAQ">MDJH</a>) were down 60% to $0.2400.</li>
<li>Starbox Group Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBX#NASDAQ">STBX</a>) was down, falling 28% to $1.48.</li>
</ul>
Commodities In commodity news, oil traded up 1.1% to $69.36 while gold traded down 0.9% at $2,775.10.
Silver traded down 2.2% to $33.325 on Thursday, while copper rose 0.3% to $4.3625.
Euro zone
European shares were lower today. The eurozone's STOXX 600 dipped 1%, Germany's DAX fell 0.5% and France's CAC 40 slipped 0.7%. Spain's IBEX 35 Index fell 0.2%, while London's FTSE 100 fell 0.9%.
Asia Pacific Markets
Asian markets closed mostly lower on Thursday, with Japan's Nikkei 225 falling 0.50%, Hong Kong's Hang Seng Index falling 0.31%, China's Shanghai Composite Index gaining 0.42% and India's BSE Sensex falling 0.69%.
Economics
<ul>
<li>U.S. initial jobless claims declined by 12,000 from the previous week to 216,000 in the week ending Oct. 26.</li>
<li>U.S. personal income increased by 0.3% from the prior month to $24.948 trillion in September, while personal spending increased by 0.5% to an annualized rate of $20.024 trillion.</li>
<li>The personal consumption expenditure price index rose 0.2% month-over-month in September following a 0.1% increase in August.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41652163/jim-cramer-this-financial-stock-is-one-of-the-most-consistent-great-companies">Jim Cramer: This Financial Stock Is &#8216;One Of The Most Consistent, Great Companies&#8217;</a></li>
</ul>

EFSH

MDJH

MSFT

STBX

Nasdaq Down Over 200 Points; Microsoft Shares Fall After Q1 Results

Needham analyst David Saxon reiterates Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Buy and maintains $13 price target.

Reiteration

Needham Reiterates Buy on Alphatec Holdings, Maintains $13 Price Target

<h3>Gainers</h3>
<ul>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) stock increased by 50.8% to $15.44 during Thursday's pre-market session. The company's market cap stands at $17.7 million. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares rose 34.96% to $4.4. The company's market cap stands at $2.4 million. </li>
<li>Aerovate Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTE#NASDAQ">AVTE</a>) shares increased by 25.56% to $2.75. The company's market cap stands at $79.3 million. </li>
<li>Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) stock increased by 24.73% to $7.01. The market value of their outstanding shares is at $984.6 million. The company's, Q3 earnings came out yesterday. </li>
<li>Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) stock increased by 14.4% to $22.0. The company's market cap stands at $3.7 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Madrigal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDGL#NASDAQ">MDGL</a>) shares increased by 13.46% to $245.0. The market value of their outstanding shares is at $5.3 billion. As per the news, the Q3 earnings report came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Matinas BioPharma Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MTNB#AMEX">MTNB</a>) stock fell 51.8% to $0.93 during Thursday's pre-market session. The company's market cap stands at $4.6 million. </li>
<li>Equillium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQ#NASDAQ">EQ</a>) shares fell 42.76% to $0.79. The company's market cap stands at $27.9 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares decreased by 21.34% to $0.5. The market value of their outstanding shares is at $7.4 million. </li>
<li>CalciMedica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALC#NASDAQ">CALC</a>) shares decreased by 19.8% to $3.85. The company's market cap stands at $41.3 million. </li>
<li>Psyence Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) shares decreased by 19.15% to $0.08. The market value of their outstanding shares is at $4.1 million. </li>
<li>Compass Pathways (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) stock decreased by 16.81% to $5.15. The market value of their outstanding shares is at $352.1 million. The company's, Q3 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMIX

AVTE

CALC

ENSC

MDGL

NVST

TNON

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) shares moved upwards by 50.8% to $15.44 during Thursday's pre-market session. The company's market cap stands at $17.7 million. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares moved upwards by 34.96% to $4.4. The company's market cap stands at $2.4 million. </li>
<li>Aerovate Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTE#NASDAQ">AVTE</a>) shares rose 25.56% to $2.75. The market value of their outstanding shares is at $79.3 million. </li>
<li>Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) shares increased by 24.73% to $7.01. The market value of their outstanding shares is at $984.6 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) stock increased by 14.4% to $22.0. The company's market cap stands at $3.7 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li>Madrigal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDGL#NASDAQ">MDGL</a>) shares moved upwards by 13.46% to $245.0. The market value of their outstanding shares is at $5.3 billion. The company's, Q3 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Matinas BioPharma Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MTNB#AMEX">MTNB</a>) shares fell 51.8% to $0.93 during Thursday's pre-market session. The market value of their outstanding shares is at $4.6 million. </li>
<li>Equillium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQ#NASDAQ">EQ</a>) stock decreased by 42.76% to $0.79. The market value of their outstanding shares is at $27.9 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares decreased by 21.34% to $0.5. The market value of their outstanding shares is at $7.4 million. </li>
<li>CalciMedica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALC#NASDAQ">CALC</a>) stock declined by 19.8% to $3.85. The company's market cap stands at $41.3 million. </li>
<li>Psyence Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) shares declined by 19.15% to $0.08. The market value of their outstanding shares is at $4.1 million. </li>
<li>Compass Pathways (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) shares fell 16.81% to $5.15. The market value of their outstanding shares is at $352.1 million. As per the news, the Q3 earnings report came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HC Wainwright &amp; Co. analyst Sean Lee reiterates Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Buy and maintains $20 price target.

HC Wainwright & Co. Reiterates Buy on Alphatec Holdings, Maintains $20 Price Target

Shares of Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) rose in today's pre-market trading after the company reported better-than-expected third-quarter<a href="https://www.benzinga.com/quote/cvna/earnings"> financial results</a>.
Carvana reported third-quarter revenue of $3.66 billion, beating the consensus estimate of $3.45 billion, according to Benzinga Pro. The used car retailer reported third-quarter earnings of 64 cents per share, beating analyst estimates of 17 cents per share.
Carvana shares jumped 20.3% to $249.39 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Root, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) gained 79.1% to $72.50 in pre-market trading following better-than-expected quarterly results.</li>
<li>1847 Holdings LLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#NASDAQ">EFSH</a>) rose 48.4% to $0.5768 in pre-market trading. 1847 Holdings announced the closing of $11.1 million public offering</li>
<li>CPS Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPSH#NASDAQ">CPSH</a>) shares surged 28.3% to $1.86 in pre-market trading after the company announced a $12 million contract to provide power module components and related solutions to a customer.</li>
<li>Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) climbed 22.4% to $6.88 in pre-market trading after the company reported better-than-expected third-quarter revenue results and raised its FY24 revenue guidance.</li>
<li>Remitly Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELY#NASDAQ">RELY</a>) shares rose 20.7% to $18.42 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates.</li>
<li>LuxUrban Hotels Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXH#NASDAQ">LUXH</a>) gained 17.8% to $0.0418 in pre-market trading after declining around 14% on Wednesday.</li>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) gained 24% to $101.36 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates.</li>
<li>Avadel Pharmaceuticals plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) gained 22.2% to $15.78 in pre-market trading. Avadel Pharmaceuticals and nference announced the publication of real-world data in sleep advances.</li>
<li>Day One Biopharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAWN#NASDAQ">DAWN</a>) shares rose 14% to $16.49 in pre-market trading after the company reported better-than-expected third-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Equillium, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQ#NASDAQ">EQ</a>) shares dipped 42% to $0.80 in pre-market trading.</li>
<li>Office Properties Income Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPI#NASDAQ">OPI</a>) shares fell 34% to $1.30 in pre-market trading after the company reported third-quarter results.</li>
<li>MDJM Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDJH#NASDAQ">MDJH</a>) shares fell 33.3% to $0.40 in pre-market trading.</li>
<li>Highest Performances Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPH#NASDAQ">HPH</a>) fell 27.5% to $0.4032 in today's pre-market trading. HPH announced results of its extraordinary general meeting and separate class meeting.</li>
<li>Elevai Labs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELAB#NASDAQ">ELAB</a>) fell 26.7% to $0.0680 in pre-market trading after declining 7% on Wednesday.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) fell 21.7% to $0.4990 in pre-market trading after jumping 54% on Wednesday.</li>
<li>CalciMedica, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALC#NASDAQ">CALC</a>) shares declined 20.8% to $3.80 in pre-market trading after the company reported the pricing of public offering of common stock.</li>
<li>Solidion Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) declined 16.4% to $0.3940 in pre-market trading. Solidion Technology shares jumped 19% on Wednesday after the company announced its battery scientists have developed a cost-effective strategy for enabling the completion of 5-minute charging for a wide range of lithium batteries.</li>
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) shares fell 15.3% to $5.62 after the company reported a wider-than-expected quarterly loss.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) fell 15.2% to $65.55 in pre-market trading after reporting third-quarter results.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/news/24/10/41622545/wall-streets-most-accurate-analysts-spotlight-on-3-risk-off-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields</a></li>
</ul>

Pre-Market Outlook

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

CPSH

CVNA

DAWN

ELAB

LUXH

RDDT

ROKU

Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

WIIM

Aplhatec shares are trading higher after the company reported better-than-expected Q3 revenue results and raised its FY24 revenue guidance.

<h3>Gainers</h3>
<ul>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares moved upwards by 28.8% to $4.2 during Wednesday's after-market session. The market value of their outstanding shares is at $2.3 million. </li>
<li>Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) shares increased by 11.21% to $6.25. The market value of their outstanding shares is at $877.9 million. The company's, Q3 earnings came out today. </li>
<li>Estrella Immunopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLA#NASDAQ">ESLA</a>) stock rose 10.79% to $0.9. The market value of their outstanding shares is at $32.8 million. </li>
<li>Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) stock rose 9.2% to $21.0. The market value of their outstanding shares is at $3.6 billion. As per the news, the Q3 earnings report came out today. </li>
<li>TFF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) stock moved upwards by 7.56% to $2.7. The market value of their outstanding shares is at $9.3 million. </li>
<li>Citius Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) stock moved upwards by 7.5% to $1.29. The company's market cap stands at $91.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Corcept Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) shares fell 16.8% to $39.0 during Wednesday's after-market session. The company's market cap stands at $4.0 billion. The company's, Q3 earnings came out today. </li>
<li>Acadia Healthcare Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) shares decreased by 13.22% to $45.2. The company's market cap stands at $4.1 billion. The company's, Q3 earnings came out today. </li>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) stock decreased by 12.77% to $0.34. The company's market cap stands at $2.4 million. </li>
<li>CareMax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) shares declined by 7.43% to $1.87. The market value of their outstanding shares is at $7.1 million. </li>
<li>Anixa Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIX#NASDAQ">ANIX</a>) stock decreased by 6.69% to $3.35. The company's market cap stands at $107.8 million. </li>
<li>Eledon Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELDN#NASDAQ">ELDN</a>) stock fell 6.31% to $3.93. The market value of their outstanding shares is at $162.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACHC

ANIX

CMAX

CORT

CTOR

ELDN

ESLA

TFFP

VERO

12 Health Care Stocks Moving In Wednesday's After-Market Session

Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) raises FY2024 sales outlook from $602.00 million to $605.00 million.

Guidance

Alphatec Holdings Raises FY2024 Sales Guidance from $602.00M to $605.00M

Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.23) by 21.74 percent. The company reported quarterly sales of $150.719 million which beat the analyst consensus estimate of $147.218 million by 2.38 percent. This is a 27.44 percent increase over sales of $118.262 million the same period last year.

Earnings Beats

Earnings Misses

Alphatec Holdings Q3 2024 GAAP EPS $(0.28) Misses $(0.23) Estimate, Sales $150.719M Beat $147.218M Estimate

Lake Street analyst Brooks O'Neil maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Buy and lowers the price target from $32 to $18.

Lake Street Maintains Buy on Alphatec Holdings, Lowers Price Target to $18

Canaccord Genuity analyst Caitlin Cronin maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Buy and maintains $20 price target.

Canaccord Genuity Maintains Buy on Alphatec Holdings, Maintains $20 Price Target

Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $18.11, a high estimate of $25.00, and a low estimate of $12.00. Experiencing a 16.85% decline, the current average is now lower than the previous average price target of $21.78. 
<img src="https://www.benzinga.com/files/images/story/2024/1724328044_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Alphatec Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Saxon</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$13.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Matt O'Brien</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$12.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Mathew Blackman</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Vik Chopra</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$19.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Sean Lee</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>David Saxon</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$23.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Caitlin Cronin</td>
<td>Canaccord Genuity</td>
<td>Maintains</td>
<td>Buy</td>
<td>$25.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Drew Ranieri</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Mathew Blackman</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$19.00</td>
<td>$24.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Alphatec Holdings. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Alphatec Holdings compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Alphatec Holdings's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Alphatec Holdings's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ATEC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Alphatec Holdings analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Alphatec Holdings</h2>
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
<h3>Key Indicators: Alphatec Holdings's Financial Health</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Alphatec Holdings's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 24.51% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Alphatec Holdings's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -27.94%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Alphatec Holdings's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -148.84%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -5.27%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 32.47, Alphatec Holdings faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Alphatec Holdings Stands With Analysts

Needham analyst David Saxon maintains Alphatec Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) with a Buy and lowers the price target from $23 to $13.

Needham Maintains Buy on Alphatec Holdings, Lowers Price Target to $13

U.S. stocks traded lower toward the end of trading, with the Dow Jones index dipping more than 650 points on Thursday.
The Dow traded down 1.61% to 40,184.39 while the NASDAQ fell 2.77% to 17,111.79. The S&amp;P 500 also fell, dropping, 1.78% to 5,424.16.
Leading and Lagging Sectors Utilities shares gained by 1.5% on Thursday.
In trading on Thursday, information technology shares fell by 4%.
Top Headline Moderna Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) stock dipped more than 20% on Thursday as the company lowered its 2024 sales guidance due to weaker demand for its COVID-19 vaccines.
Moderna now projects 2024 net sales of between $3 billion and $3.5 billion from its respiratory franchise versus previous guidance of about $4 billion, citing low EU sales in 2024, potential revenue deferrals for certain international sales into 2025, and an increasingly competitive environment for respiratory vaccines in the U.S.
Moderna reported second-quarter revenue of $241 million, compared with $344 million a year earlier, beating the consensus of $132.18 million.
Net loss was $1.28 billion, or $3.33 a share, versus a loss of $1.38 billion, or $3.62 a share, a year earlier, surpassing the consensus of $(3.36).
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>RedHill Biopharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) shares shot up 80% to $0.69 after the company announced a new publication showed data demonstrating that triple antimicrobial therapy with RHB-104 plus standard of care, targeting Mycobacterium avium subspecies paratuberculosis, is 64% more effective than SoC alone in Crohn&#8217;s disease.</li>
<li>Shares of Exact Sciences Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) got a boost, surging 23% to $56.26&nbsp;after the company reported better-than-expected second-quarter financial results. Also, the company announced an exclusive license agreement with TwinStrand Biosciences.</li>
<li>Omnicell, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMCL#NASDAQ">OMCL</a>) shares were also up, gaining 31% to $38.20 after the company reported better-than-expected second-quarter financial results and issued FY24 guidance above estimates.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Vintage Wine Estates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VWE#NASDAQ">VWE</a>) shares dropped 41% to $0.0305 after the company announced a bankruptcy filing and a voluntary delisting and SEC deregistration.</li>
<li>Shares of ALX Oncology Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) were down 40% to $2.89. The company released topline data from its Phase 2 ASPEN-06 clinical trial.</li>
<li>Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) was down, falling 29% to $7.15 after the company reported mixed second-quarter financial results.</li>
</ul>
Commodities In commodity news, oil traded down 1.8% to $76.53 while gold traded up 0.3% at $2,481.50.
Silver traded down 1.9% to $28.395 on Thursday, while copper fell 2.8% to $4.0595.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 1.23%, Germany's DAX fell 2.30% and France's CAC 40 fell 2.14%. Spain's IBEX 35 Index fell 1.9%, while London's FTSE 100 fell 1.01%.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei 225 dipping 2.49%, Hong Kong's Hang Seng Index falling 0.23% and S&amp;P BSE Sensex gaining 0.15%.
Economics
<ul>
<li>The ISM manufacturing PMI declined to 46.6 in July versus 48.5 in the prior month, below market estimates of 48.8.</li>
<li>Construction spending declined by 0.3% month-over-month to an annual rate of $2,148 billion in June.</li>
<li>U.S. initial jobless claims by 14,000 to 249,000 in the week ending July 27th, beating market estimates of 236,000.</li>
<li>Nonfarm business sector labor productivity increased by 2.3% in the second quarter, compared to a revised 0.4% rise in the prior period.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40101200/top-3-health-care-stocks-that-are-set-to-fly-this-quarter">Top 3 Health Care Stocks That Are Set To Fly This Quarter</a></li>
</ul>

ALXO

EXAS

MRNA

OMCL

RDHL

Vintage Wine Estates, Inc. - Common Stock

Crude Oil Moves Lower; Moderna Shares Plunge

U.S. stocks traded lower midway through trading, with the Dow Jones index dipping more than 500 points on Thursday.
The Dow traded down 1.26% to 40,327.48 while the NASDAQ fell 1.57% to 17,322.26. The S&amp;P 500 also fell, dropping, 1.05% to 5,464.56.
Leading and Lagging Sectors Communication services shares gained by 1.1% on Thursday.
In trading on Thursday, information technology shares fell by 2.3%.
Top Headline The ISM manufacturing PMI declined to 46.6 in July versus 48.5 in the prior month, below market estimates of 48.8.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>RedHill Biopharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) shares shot up 56% to $0.6008 after the company announced a new publication showed data demonstrating that triple antimicrobial therapy with RHB-104 plus standard of care, targeting Mycobacterium avium subspecies paratuberculosis, is 64% more effective than SoC alone in Crohn&#8217;s disease.</li>
<li>Shares of Exact Sciences Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) got a boost, surging 24% to $56.70&nbsp;after the company reported better-than-expected second-quarter financial results. Also, the company announced an exclusive license agreement with TwinStrand Biosciences.</li>
<li>Omnicell, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMCL#NASDAQ">OMCL</a>) shares were also up, gaining 28% to $37.29 after the company reported better-than-expected second-quarter financial results and issued FY24 guidance above estimates.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Vintage Wine Estates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VWE#NASDAQ">VWE</a>) shares dropped 34% to $0.0342 after the company announced a bankruptcy filing and a voluntary delisting and SEC deregistration.</li>
<li>Shares of ALX Oncology Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) were down 37% to $3.0250. The company released topline data from its Phase 2 ASPEN-06 clinical trial.</li>
<li>Alphatec Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEC#NASDAQ">ATEC</a>) was down, falling 23% to $7.80 after the company reported mixed second-quarter financial results.</li>
</ul>
Commodities In commodity news, oil traded down 0.8% to $77.26 while gold traded up 0.7% at $2,489.90.
Silver traded down 1% to $28.655 on Thursday, while copper fell 1.9% to $4.0975.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 1.23%, Germany's DAX fell 2.32% and France's CAC 40 fell 2.14%. Spain's IBEX 35 Index fell 1.9%, while London's FTSE 100 fell 1.01%.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei 225 dipping 2.49%, Hong Kong's Hang Seng Index falling 0.23% and S&amp;P BSE Sensex gaining 0.15%.
Economics
<ul>
<li>The ISM manufacturing PMI declined to 46.6 in July versus 48.5 in the prior month, below market estimates of 48.8.</li>
<li>Construction spending declined by 0.3% month-over-month to an annual rate of $2,148 billion in June.</li>
<li>U.S. initial jobless claims by 14,000 to 249,000 in the week ending July 27th, beating market estimates of 236,000.</li>
<li>Nonfarm business sector labor productivity increased by 2.3% in the second quarter, compared to a revised 0.4% rise in the prior period.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40101200/top-3-health-care-stocks-that-are-set-to-fly-this-quarter"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40101200/top-3-health-care-stocks-that-are-set-to-fly-this-quarter">Top 3 Health Care Stocks That Are Set To Fly This Quarter</a></li>
</ul>

Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Microsoft (MSFT) reported better-than-...

Microsoft reports Q1 beat, Comcast weighs cable networks spinoff: Morning Buzz

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IQVIA Holdings (IQV – Research Report), Alphatec Hol...

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Alphatec Holdings (ATEC) and Alnylam Pharma (ALNY)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alphatec Holdings (ATEC – Research Report), Cigna ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alphatec Holdings (ATEC), Cigna (CI) and Intuitive Surgical (ISRG)

In a report released yesterday, Caitlin Cronin from Canaccord Genuity maintained a Buy rating on Alphatec Holdings (ATEC – Research Report), with a...

Alphatec Holdings: Promising Financial Trajectory and Growth Potential Amid Strategic Investments and Revenue Recovery

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS – Research Report), Avanos Medical (AVNS...

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Avanos Medical (AVNS) and Alphatec Holdings (ATEC)

16:17 EST Alphatec (ATEC) files to sell 1.13M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mar...

Alphatec files to sell 1.13M shares of common stock for holders

Alphatec files to sell 1.13M shares of common stocks by selling shareholders

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Alphatec Holdings (ATEC – Research Report), with a price target of...

Alphatec Holdings (ATEC) Gets a Buy from Barclays

Barclays analyst Matt Miksic raised the firm's price target on Alphatec (ATEC) to $20 from $19 and keeps an Overweight rating on the shares. After ...

Alphatec price target raised to $20 from $19 at Barclays

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B...

Comments

Alphatec Holdings

空売り

Alphatec Holdings (NASDAQ:ATEC) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル